Downregulation of Ras Association Domain Family Member 6 (RASSF6) Underlies the Treatment Resistance of Highly Metastatic Nasopharyngeal Carcinoma Cells. This evidence concerns the gene RASSF6 and nasopharyngeal carcinoma.